atai Life Sciences Announces Positive Preliminary Results from Phase 1b Trial of VLS-01 (Buccal Film DMT)

Go back to atai Life Sciences Announces Positive Preliminary Results from Phase 1b Trial of VLS-01 (Buccal Film DMT)
ATA, Inc. (NASDAQ: ATAI) Delayed: 4.05 -0.01 (0.25%)
Previous Close $4.06    52 Week High $7.32 
Open $4.17    52 Week Low $3.30 
Day High $4.23    P/E N/A 
Day Low $4.03    EPS $0.00 
Volume 5,427,966